A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors

NCT05784870 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancy
Cancer-Related Anemia

Interventions

DRUG: Shengxuening Tablet
DRUG: Ferrous succinate

Sponsor

Zhongnan Hospital